Global Cardiac Rhythm Management Devices Market Research Report to 2027 – Featuring Abbott Laboratories, ACS Diagnostics and Biotronik Among Others

DUBLIN, April 08, 2022– (BUSINESS WIRE) – The “Cardiac Rhythm Management Devices Market Research Report by Product (Cardiac Resynchronization Therapy, Defibrillators, and Pacemakers), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19 “report has been added to ResearchAndMarkets.com’s offering.

The Global Cardiac Rhythm Management Devices Market size was estimated at USD 18.73 billion in 2021 and expected to reach USD 20.55 billion in 2022, and is projected to grow at a CAGR 9.88% to reach USD 32.97 billion by 2027.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and updates reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States.

This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cardiac Rhythm Management Devices market considering the current update on the conflict and its global response.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analysis penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cardiac Rhythm Management Devices Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cardiac Rhythm Management Devices Market during the forecast period?

3. Which are the products / segments / applications / areas to invest in over the forecast period in the Global Cardiac Rhythm Management Devices Market?

4. What is the competitive strategic window for opportunities in the Global Cardiac Rhythm Management Devices Market?

5. What are the technology trends and regulatory frameworks in the Global Cardiac Rhythm Management Devices Market?

6. What is the market share of the leading vendors in the Global Cardiac Rhythm Management Devices Market?

7. What modes and strategic moves are considered suitable for entering the Global Cardiac Rhythm Management Devices Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers

5.1.1.1. Increasing prevalence of heart failures

5.1.1.2. Growing use of photoplethysmography technology in wearables for atrial fibrillation (AFib) detection

5.1.1.3. Rising investments and grants for research on CM & CRM devices

5.1.2. Restraints

5.1.2.1. Product recalls

5.1.3. Opportunities

5.1.3.1. Product enhancement with advanced technology support

5.1.3.2. Increasing expenditure on healthcare services

5.1.4. Challenges

5.1.4.1. Dearth of skilled professionals with knowledge and expertise in electrocardiography and cardiac

5.2. Cumulative Impact of COVID-19

5.3. Cumulative Impact of 2022 Russia Ukraine Conflict

6. Cardiac Rhythm Management Devices Market, by Product

7. Cardiac Rhythm Management Devices Market, by End User

8. Americas Cardiac Rhythm Management Devices Market

9. Asia-Pacific Cardiac Rhythm Management Devices Market

10. Europe, Middle East & Africa Cardiac Rhythm Management Devices Market

11. Competitive Landscape

12. Company Usability Profiles

12.1. Abbott Laboratories

12.2. ACS Diagnostics

12.3. Alivecor, Inc.

12.4. Asahi Kasei Corporation

12.5. Bexen Cardio

12.6. Biotelemetry

12.7. Biotronics

12.8. Boston Scientific Corporation

12.9. BPL Medical Technologies

12.10. BTL

12.11. GE Healthcare

12.12. Hill-Rom Holdings, Inc.

12.13. Royal Philips NV

12.14. Lepu Medical Technology

12.15. Medtronic Plc

12.16. Metrax Gmbh

12.17. Microport Scientific Corporation

12.18. Narang Medical Limited

12.19. Nihon Kohden Corporation

12.20. Osypka AG

12.21. Schiller AG

12.22. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

13. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/fivy80

View source version on businesswire.com: https://www.businesswire.com/news/home/20220408005240/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For US / CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call + 353-1-416-8900

Leave a Comment